Key facts
- This page summarizes John C. Leo's Form 4 filing for Healthcare Triangle, Inc. (HCTI).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 Nov 2022, 15:22.
John C. Leo - 09 Nov 2022 Form 4 Insider Report for Healthcare Triangle, Inc. (HCTI)
- Reporting relationship
- Director
- Issuer ticker
- HCTI
- Reported as of
- 09 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Nov 2022, 15:22:00 UTC
- Prior SEC filing
- 10 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Leo
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John C. Leo filed Form 4 for Healthcare Triangle, Inc. (HCTI) on 14 Nov 2022.
Change
- Previous filing in this sequence was filed on 10 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HCTI
holding
Derivative
Non-qualified Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,000
- Date
- 09 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $2.25
- Footnotes
- F1, F2
HCTI
holding
Derivative
Stock Option (Right To Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,000
- Date
- 09 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $0.1900
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The expiration date is the earlier of August 14, 2026 or 18 months after the date the optionee is no longer a member of the Board of Directors of the Company.
Footnote F2
Non-qualified stock option granted on December 2, 2021 which will vest on December 2, 2022.
Footnote F3
Non-qualified stock option granted 11/09/2022 under the Company's 2020 Plan. The options vested immediately, and are for a 5-year period or 18 months after the date the optionee is no longer a member of the Board of Directors of the Company.